Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 190

1.

PO-60 - Renal tumors with extensive vascular disease: management challenges in a pediatric series from the Hospital for Sick Children.

Zamperlini-Netto G, Zanette A, Wehbi E, Williams S, Grant RM, Brandao LR.

Thromb Res. 2016 Apr;140 Suppl 1:S198-9. doi: 10.1016/S0049-3848(16)30193-1. Epub 2016 Apr 8.

PMID:
27161746
2.

Effectiveness and safety of oral HIV pre-exposure prophylaxis (PrEP) for all populations: A systematic review and meta-analysis.

Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'reilly KR, Koechlin FM, Rodolph M, Hodges-Mameletzis I, Grant RM.

AIDS. 2016 May 5. [Epub ahead of print]

PMID:
27149090
3.

PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply.

Sevelius J, Deutsch MB, Glidden DV, Grant RM.

Lancet HIV. 2016 May;3(5):e200-1. doi: 10.1016/S2352-3018(16)30023-6. No abstract available.

PMID:
27126486
4.

The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study.

Mehrotra ML, Glidden DV, McMahan V, Amico KR, Hosek S, Defechereux P, Mayer KH, Veloso VG, Bekker LG, Avelino-Silva VI, Schechter M, Grant RM.

AIDS Behav. 2016 Apr 28. [Epub ahead of print]

PMID:
27125241
5.

HIV moments and pre-exposure prophylaxis.

Grant RM, Glidden DV.

Lancet. 2016 Apr 9;387(10027):1507-8. doi: 10.1016/S0140-6736(16)30125-8. Epub 2016 Apr 7. No abstract available.

PMID:
27115970
6.

Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.

Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, McMahan V, Mayer KH, David B, Schechter M, Grinsztejn B, Guanira J, Grant RM.

Clin Infect Dis. 2016 May 1;62(9):1172-7. doi: 10.1093/cid/ciw022. Epub 2016 Jan 20.

PMID:
26797207
7.

Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial.

Kuebler PJ, Shaw BI, Leadabrand KS, Mehrotra ML, Grant RM, Kallás EG, Nixon DF.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):184-8. doi: 10.1097/QAI.0000000000000923.

PMID:
26674373
8.

Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.

Yacoub R, Nadkarni GN, Weikum D, Konstantinidis I, Boueilh A, Grant RM, Mugwanya KK, Baeten JM, Wyatt CM.

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e115-8. doi: 10.1097/QAI.0000000000000906. No abstract available.

PMID:
26627105
9.

HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.

Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM; iPrEx investigators.

Lancet HIV. 2015 Dec;2(12):e512-9. doi: 10.1016/S2352-3018(15)00206-4. Epub 2015 Nov 6.

PMID:
26614965
10.

What people want from sex and preexposure prophylaxis.

Grant RM, Koester KA.

Curr Opin HIV AIDS. 2016 Jan;11(1):3-9. doi: 10.1097/COH.0000000000000216.

PMID:
26569183
11.

Integrating Antiretroviral Strategies for Human Immunodeficiency Virus Prevention: Post- and Pre-Exposure Prophylaxis and Early Treatment.

Grant RM, Smith DK.

Open Forum Infect Dis. 2015 Aug 26;2(4):ofv126. doi: 10.1093/ofid/ofv126. eCollection 2015 Dec. Review.

12.

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Solomon MM, Schechter M, Liu AY, McManhan VM, Guanira JV, Hance RJ, Chariyalertsak S, Mayer KH, Grant RM; iPrEx Study Team.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):281-6. doi: 10.1097/QAI.0000000000000857.

13.

Editorial Commentary: Keeping Our Eyes on the Prize: No New HIV Infections With Increased Use of HIV Pre-exposure Prophylaxis.

Koester KA, Grant RM.

Clin Infect Dis. 2015 Nov 15;61(10):1604-5. doi: 10.1093/cid/civ783. Epub 2015 Sep 1. No abstract available.

14.

Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.

Kuebler PJ, Mehrotra ML, Shaw BI, Leadabrand KS, Milush JM, York VA, Defechereux P, Grant RM, Kallás EG, Nixon DF.

J Infect Dis. 2016 Feb 15;213(4):569-73. doi: 10.1093/infdis/jiv425. Epub 2015 Aug 26.

PMID:
26310308
15.

Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis.

Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, Jaremko JL, Ho J, Shenouda N, Matzinger MA, Lentle B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lang B, Israels S, Grant RM, Couch R, Barr R, Hay J, Rauch F, Siminoski K, Ward LM; Canadian STOPP Consortium (National Pediatric Bone Health Working Group).

J Clin Endocrinol Metab. 2015 Sep;100(9):3408-17. doi: 10.1210/JC.2015-2176. Epub 2015 Jul 14.

PMID:
26171800
16.

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.

Kuebler PJ, Mehrotra ML, McConnell JJ, Holditch SJ, Shaw BI, Tarosso LF, Leadabrand KS, Milush JM, York VA, Raposo RA, Cheng RG, Eriksson EM, McMahan V, Glidden DV, Shiboski S, Grant RM, Nixon DF, Kallás EG.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8379-84. doi: 10.1073/pnas.1501443112. Epub 2015 Jun 22.

17.

Ending sexual HIV transmission: lessons learned from perinatal HIV.

Weber S, Grant RM.

J Assoc Nurses AIDS Care. 2015 Sep-Oct;26(5):520-5. doi: 10.1016/j.jana.2015.05.005. Epub 2015 Jun 19. No abstract available.

PMID:
26096627
18.

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).

Defechereux PA, Mehrotra M, Liu AY, McMahan VM, Glidden DV, Mayer KH, Vargas L, Amico KR, Chodacki P, Fernandez T, Avelino-Silva VI, Burns D, Grant RM; iPrEx Study Team.

AIDS Behav. 2015 Jun 16. [Epub ahead of print]

PMID:
26078115
19.

Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study.

Koester KA, Liu A, Eden C, Amico KR, McMahan V, Goicochea P, Hosek S, Mayer KH, Grant RM.

AIDS Care. 2015;27(10):1199-204. doi: 10.1080/09540121.2015.1039958. Epub 2015 May 22.

PMID:
26001026
20.

Brief Report: Recent Infection, Sexually Transmitted Infections, and Transmission Clusters Frequently Observed Among Persons Newly Diagnosed With HIV in San Francisco.

Truong HM, Pipkin S, OʼKeefe KJ, Louie B, Liegler T, McFarland W, Grant RM, Bernstein K, Scheer S.

J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):606-9. doi: 10.1097/QAI.0000000000000681.

PMID:
25967271
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk